About
Technology
Issues
FAQ
Links
Official Page
Post‐marketing analysis for biosimilar CT‐P13 in inflammatory bowel disease compared with external data of originator infliximab in Japan
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.